Opioid players down premarket on start of Ohio trial

Teva Pharmaceutical Industries (NYSE:TEVA) (-4%), Endo International (NASDAQ:ENDP) (-11%) and Cardinal Health (NYSE:CAH) (-3%) are under modest pressure premarket ahead of the start of an opioid epidemic-related trial in Cleveland, OH. Two counties are suing certain companies over their role in the crisis there.

Update: Mallinckrodt (NYSE:MNK) is down 6% premarket and McKesson (NYSE:MCK) is down 4%. Medical products distributor Henry Schein (NASDAQ:HSIC) has been dismissed from the lawsuit.